PremiumRatingsUS Physical Therapy: Strong Performance and Growth Potential Justify Buy Rating US Physical Therapy Reports Strong Q1 2025 Results U.S. Physical Therapy reports Q1 operating EPS 48c, consensus 45c PremiumThe FlyU.S. Physical Therapy acquires three-clinic physical therapy practice in Wyoming U.S. Physical Therapy price target lowered to $98 from $108 at Barrington U.S. Physical Therapy: Strong Financials and Strategic Growth Drive Buy Rating PremiumThe FlyU.S. Physical Therapy sees FY25 adjusted EBITDA $88M-$93M U.S. Physical Therapy reports Q4 operating EPS 51c, consensus 70c USPH Earnings this Week: How Will it Perform?